X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
index medicus (5) 5
female (4) 4
infectious diseases (4) 4
tuberculosis (4) 4
antitubercular agents - therapeutic use (3) 3
patients (3) 3
studies (3) 3
xdr-tb (3) 3
adult (2) 2
adults (2) 2
amikacin - therapeutic use (2) 2
analysis (2) 2
antitubercular agents (2) 2
capreomycin - therapeutic use (2) 2
care and treatment (2) 2
clinical trials (2) 2
drug resistance (2) 2
drug resistance in microorganisms (2) 2
drug therapy (2) 2
drugs (2) 2
epidemiology (2) 2
extensively drug-resistant tuberculosis - drug therapy (2) 2
fluoroquinolones - therapeutic use (2) 2
gene expression (2) 2
health aspects (2) 2
kanamycin - therapeutic use (2) 2
levofloxacin (2) 2
literature reviews (2) 2
male (2) 2
mdr-tb (2) 2
medicine (2) 2
medicine, general & internal (2) 2
meta-analysis (2) 2
mycobacterium-tuberculosis (2) 2
patient outcomes (2) 2
program (2) 2
pulmonary tuberculosis (2) 2
recurrence (2) 2
regimens (2) 2
systematic review (2) 2
treatment failure (2) 2
treatment outcomes (2) 2
abnormalities, multiple - diagnosis (1) 1
abnormalities, multiple - genetics (1) 1
abnormalities, multiple - metabolism (1) 1
abnormalities, multiple - physiopathology (1) 1
abridged index medicus (1) 1
adjustment (1) 1
adolescent (1) 1
aged (1) 1
aged, 80 and over (1) 1
amikacin (1) 1
amoxicillin (1) 1
antitubercular agents - administration & dosage (1) 1
antitubercular agents - classification (1) 1
antitubercular agents - standards (1) 1
bacterial infections (1) 1
base sequence (1) 1
bedaquiline (1) 1
biochemistry & molecular biology (1) 1
biology (1) 1
biomarkers (1) 1
blood pressure (1) 1
bulking agents (1) 1
c-reactive protein (1) 1
canine (1) 1
capreomycin (1) 1
carbapenems (1) 1
carbapenems - therapeutic use (1) 1
cardiac function (1) 1
cardiology (1) 1
cardiovascular dysfunction (1) 1
cardiovascular monitoring (1) 1
case report (1) 1
categories (1) 1
cells (1) 1
chemistry (1) 1
chemistry, multidisciplinary (1) 1
child (1) 1
chromatin (1) 1
circulating micrornas (1) 1
clavulanic acid (1) 1
clinical outcomes (1) 1
clofazimine (1) 1
clofazimine - therapeutic use (1) 1
codon, nonsense (1) 1
cohort (1) 1
confidence intervals (1) 1
congenital anomalies (1) 1
congenital defects (1) 1
control methods (1) 1
cross-resistance (1) 1
data analysis (1) 1
data processing (1) 1
developmental delay (1) 1
diagnosis (1) 1
diagnostic systems (1) 1
diagnostic tests (1) 1
diarylquinolines - therapeutic use (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Ahmad, Nafees and Ahuja, Shama D and Akkerman, Onno W and Alffenaar, Jan-Willem C and Anderson, Laura F and Baghaei, Parvaneh and Bang, Didi and Barry, Pennan M and Bastos, Mayara L and Behera, Digamber and Benedetti, Andrea and Bisson, Gregory P and Boeree, Martin J and Bonnet, Maryline and Brode, Sarah K and Brust, James C M and Cai, Ying and Caumes, Eric and Cegielski, J Peter and Centis, Rosella and Chan, Pei-Chun and Chan, Edward D and Chang, Kwok-Chiu and Charles, Macarthur and Cirule, Andra and Dalcolmo, Margareth Pretti and D'Ambrosio, Lia and de Vries, Gerard and Dheda, Keertan and Esmail, Aliasgar and Flood, Jennifer and Fox, Gregory J and Fréchet-Jachym, Mathilde and Fregona, Geisa and Gayoso, Regina and Gegia, Medea and Gler, Maria Tarcela and Gu, Sue and Guglielmetti, Lorenzo and Holtz, Timothy H and Hughes, Jennifer and Isaakidis, Petros and Jarlsberg, Leah and Kempker, Russell R and Keshavjee, Salmaan and Khan, Faiz Ahmad and Kipiani, Maia and Koenig, Serena P and Koh, Won-Jung and Kritski, Afranio and Kuksa, Liga and Kvasnovsky, Charlotte L and Kwak, Nakwon and Lan, Zhiyi and Lange, Christoph and Laniado-Laborín, Rafael and Lee, Myungsun and Leimane, Vaira and Leung, Chi-Chiu and Leung, Eric Chung-Ching and Li, Pei Zhi and Lowenthal, Phil and Maciel, Ethel L and Marks, Suzanne M and Mase, Sundari and Mbuagbaw, Lawrence and Migliori, Giovanni B and Milanov, Vladimir and Miller, Ann C and Mitnick, Carole D and Modongo, Chawangwa and Mohr, Erika and Monedero, Ignacio and Nahid, Payam and Ndjeka, Norbert and O'Donnell, Max R and Padayatchi, Nesri and Palmero, Domingo and Pape, Jean William and Podewils, Laura J and Reynolds, Ian and Riekstina, Vija and Robert, Jérôme and Rodriguez, Maria and Seaworth, Barbara and Seung, Kwonjune J and Schnippel, Kathryn and Shim, Tae Sun and Singla, Rupak and Smith, Sarah E and Sotgiu, Giovanni and Sukhbaatar, Ganzaya and Tabarsi, Payam and Tiberi, Simon and Trajman, Anete and Trieu, Lisa and Udwadia, Zarir F and van der Werf, Tjip S and Veziris, Nicolas and Viiklepp, Piret and ... and Collaborative Grp Meta-Analysis In and Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017
The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 821 - 834
Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of... 
DRUG | SURGERY | SOUTH-AFRICA | BEDAQUILINE | MEDICINE, GENERAL & INTERNAL | HIGH-RATES | MANAGEMENT | SAFETY | XDR-TB | REGIMENS | PROGRAM | Clofazimine - therapeutic use | Recurrence | Tuberculosis, Multidrug-Resistant - mortality | Linezolid - therapeutic use | Humans | Fluoroquinolones - therapeutic use | Tuberculosis, Pulmonary - drug therapy | Kanamycin - therapeutic use | Moxifloxacin | Capreomycin - therapeutic use | Amikacin - therapeutic use | Carbapenems - therapeutic use | Tuberculosis, Pulmonary - mortality | Diarylquinolines - therapeutic use | Treatment Failure | Antitubercular Agents - administration & dosage | Levofloxacin - therapeutic use | Drug Therapy, Combination | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Drug resistance in microorganisms | Care and treatment | Tuberculosis | Patient outcomes | Analysis | Drugs | Fluoroquinolones | Linezolid | Levofloxacin | Amikacin | Medical services | Clinical trials | Systematic review | Drug resistance | Success | Clinical outcomes | Literature reviews | Heterogeneity | Kanamycin | Data analysis | Clofazimine | Adjustment | Mortality | Data processing | Thorax | Regression analysis | Disease control | Patients | Capreomycin | Meta-analysis | Studies | Multidrug resistant organisms | Infectious diseases | Adults | Respiration | Carbapenems
Journal Article
by Ahuja, Shama D and Ashkin, David and Avendano, Monika and Banerjee, Rita and Bauer, Melissa and Bayona, Jamie N and Becerra, Mercedes C and Benedetti, Andrea and Burgos, Marcos and Centis, Rosella and Chan, Eward D and Chiang, Chen-Yuan and Cox, Helen and D'Ambrosio, Lia and DeRiemer, Kathy and Dung, Nguyen Huy and Enarson, Donald and Falzon, Dennis and Flanagan, Katherine and Flood, Jennifer and Garcia-Garcia, Maria L and Gandhi, Neel and Granich, Reuben M and Hollm-Delgado, Maria G and Holtz, Timothy H and Iseman, Michael D and Jarlsberg, Leah G and Keshavjee, Salmaan and Kim, Hye-Ryoun and Koh, Won-Jung and Lancaster, Joey and Lange, Christophe and de Lange, Wiel C. M and Leimane, Vaira and Leung, Chi Chiu and Li, Jiehui and Menzies, Dick and Migliori, Giovanni B and Mishustin, Sergey P and Mitnick, Carole D and Narita, Masa and O'Riordan, Philly and Pai, Madhukar and Palmero, Domingo and Park, Seung-kyu and Pasvol, Geoffrey and Peña, Jose and Pérez-Guzmán, Carlos and Quelapio, Maria I. D and Ponce-de-Leon, Alfredo and Riekstina, Vija and Robert, Jerome and Royce, Sarah and Schaaf, H. Simon and Seung, Kwonjune J and Shah, Lena and Shim, Tae Sun and Shin, Sonya S and Shiraishi, Yuji and Sifuentes-Osornio, José and Sotgiu, Giovanni and Strand, Matthew J and Tabarsi, Payam and Tupasi, Thelma E and van Altena, Robert and van der Walt, Martie and van der Werf, Tjip S and Vargas, Mario H and Viiklepp, Pirett and Westenhouse, Janice and Yew, Wing Wai and Yim, Jae-Joon and Collaborative Grp Meta-Anal and Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB
PLoS Medicine, ISSN 1549-1277, 08/2012, Volume 9, Issue 8, p. e1001300
Background: Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual... 
STANDARDIZED REGIMENS | PHILIPPINES | MEDICINE, GENERAL & INTERNAL | FOLLOW-UP | SHORT-COURSE CHEMOTHERAPY | DOTS-PLUS | COHORT | DRUG-RESISTANCE | INTERVENTION | PROGRAM | Patient outcomes | Pulmonary tuberculosis | Physiological aspects | Research | Drug therapy | Drug resistance | Health aspects | Meta-analysis | Studies | Clinical trials | Tuberculosis
Journal Article
International Urogynecology Journal, ISSN 0937-3462, 9/2018, Volume 29, Issue 9, pp. 1239 - 1247
The aim of the present systematic review and meta-analysis was to assess the effectiveness and safety of injections of the new bulking agent Urolastic® in the... 
Urinary incontinence | Medicine & Public Health | Gynecology | Urolastic | Stress urinary incontinence | Urology | Bulking agents | Female | Urinary Incontinence, Stress - therapy | Humans | Titanium - therapeutic use | Dimethylpolysiloxanes - therapeutic use | Safety regulations | Drug therapy | Analysis | Systematic review
Journal Article
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 01/2018, Volume 19, Issue 1, p. 82
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.